Quan Wu
- Ophthalmology top 2%
- Retinal Diseases and Treatments 6
- Cell Biology top 10%
-
- Histone Deacetylase Inhibitors Research 5
- Retinoids in leukemia and cellular processes 4
- Ubiquitin and proteasome pathways 4
- Hepatology top 10%
- Liver physiology and pathology 4
-
- Peptidase Inhibition and Analysis 5
-
- Acute Myeloid Leukemia Research 3
-
- Cancer, Hypoxia, and Metabolism 3
- Journals
- Scientific Reports (3 papers)Journal of Proteome Research (3 papers)Journal of Biological Chemistry (3 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Quan Wu
32 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 74
- Ophthalmology 291
- Cell Biology 179
- Radiology, Nuclear Medicine and Imaging 236
- Molecular Biology 623
- Hepatology 59
Countries citing papers authored by Quan Wu
This map shows the geographic impact of Quan Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Quan Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Quan Wu more than expected).
Fields of papers citing papers by Quan Wu
This network shows the impact of papers produced by Quan Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Quan Wu. The network helps show where Quan Wu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Quan Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2022 | 18 | |
| 3 | 2020 | 1 | |
| 4 | 2019 | 48 | |
| 5 | 2019 | 3 | |
| 6 | 2018 | 50 | |
| 7 | 2017 | 11 | |
| 8 | 2016 | 36 | |
| 9 | 2015 | 78 | |
| 10 | 2014 | 10 | |
| 11 | 2014 | 149 | |
| 12 | 2014 | 31 | |
| 13 | 2013 | 85 | |
| 14 | 2013 | 35 | |
| 15 | 2011 | 31 | |
| 16 | 2009 | 26 | |
| 17 | 2009 | 22 | |
| 18 | 2008 | 65 | |
| 19 | 2008 | 65 | |
| 20 | 2007 | 18 |
About Quan Wu
Quan Wu is a scholar working on Ophthalmology, Hepatology and Molecular Biology, having authored 32 papers that have together received 1.0k indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (6 papers), Peptidase Inhibition and Analysis (5 papers), Histone Deacetylase Inhibitors Research (5 papers), Liver physiology and pathology (4 papers), Retinoids in leukemia and cellular processes (4 papers), Ubiquitin and proteasome pathways (4 papers), Acute Myeloid Leukemia Research (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). The work is most often cited by research in Ophthalmology (291 citations), Cell Biology (179 citations) and Radiology, Nuclear Medicine and Imaging (236 citations). Quan Wu has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Hongmei Luo, Zhiwei Wu, Wenting Li, Lejie Cao, Pingsheng Fan, Fengsong Wang, Ke Xiao, Shibo Tang, Xiaoling Liu and Chuanlong Zhu. Their work appears in journals such as Scientific Reports, Journal of Proteome Research, Journal of Biological Chemistry, Journal of Cancer and Retina.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.